Qube Research & Technologies (QRT)
TXG icon

Qube Research & Technologies (QRT)’s 10x Genomics TXG Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$799K Sell
37,655
-207,981
-85% -$4.16M ﹤0.01% 2581
2025
Q4 		$4.01M Buy
245,636
+135,492
+123% +$2.05M ﹤0.01% 1897
2025
Q3 		$1.29M Buy
+110,144
New +$1.44M ﹤0.01% 2416
2024
Q4 		– Sell
-65,225
Closed -$1.47M – 3835
2024
Q3 		$1.47M Sell
65,225
-554,777
-89% -$11.5M ﹤0.01% 1878
2024
Q2 		$12.1M Buy
620,002
+236,298
+62% +$6.19M 0.02% 829
2024
Q1 		$14.4M Buy
+383,704
New +$16.9M 0.02% 692
2023
Q3 		– Sell
-17,022
Closed -$951K – 4340
2023
Q2 		$951K Buy
+17,022
New +$921K ﹤0.01% 1322
2023
Q1 		– Sell
-33,697
Closed -$1.23M – 3035
2022
Q4 		$1.23M Buy
+33,697
New +$1.1M 0.01% 1129
2021
Q3 		– Sell
-13,573
Closed -$2.66M – 2790
2021
Q2 		$2.66M Buy
+13,573
New +$2.46M 0.03% 598
2021
Q1 		– Sell
-16,685
Closed -$2.36M – 2430
2020
Q4 		$2.36M Buy
16,685
+12,227
+274% +$1.77M 0.03% 553
2020
Q3 		$556K Buy
+4,458
New +$468K 0.01% 996

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TXG Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its 10x Genomics (TXG) stake by 85% in Q1 2026, selling an estimated $4.16M and leaving 37,655 shares worth $799K. The position accounts for ﹤0.01% of the portfolio, ranked #2581.

Qube Research & Technologies (QRT) first reported a position in TXG in Q3 2020 and has held it in 11 quarters since. The position peaked at $14.4M in Q1 2024. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Qube Research & Technologies (QRT) held 37,655 shares of 10x Genomics worth $799K as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 207,981 10x Genomics shares in Q1 2026, an estimated $4.16M.
  • 10x Genomics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2581 holding.
  • Qube Research & Technologies (QRT) first reported a position in 10x Genomics in Q3 2020 and has held it in 11 quarters since.
  • Qube Research & Technologies (QRT)'s 10x Genomics position peaked at $14.4M in Q1 2024.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.